Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Compensated Liver Cirrhosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05538546
What this trial is testing

Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients

Who this might be right for
CirrhosisVaricesNon-invasive Evaluation
Huashan Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT01483742
What this trial is testing

Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 43
Not applicableStudy completedNCT05367596
What this trial is testing

OPTIMIzing muScle Preservation in paTients wIth Cirrhosis

Who this might be right for
ObesityCompensated CirrhosisSarcopenia
University of Kansas Medical Center 20
Not applicableUnknownNCT05357599
What this trial is testing

The Use of Endoscopic Ultrasound-Guided Portal Pressure Measurements to Guide Beta-Blocker Therapy in Patients With Compensated Cirrhosis

Who this might be right for
CirrhosisCompensated CirrhosisPortal Hypertension
University of Southern California 30
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Not applicableStudy completedNCT03071133
What this trial is testing

Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 344
Not applicableEnded earlyNCT03658551
What this trial is testing

Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy

Who this might be right for
Cirrhosis, Liver
Johannes Gutenberg University Mainz 15
Not applicableStudy completedNCT06288828
What this trial is testing

The Efficacy of Aerobic Exercise Training on ANS and Endothelial Function in Compensated Cirrhosis

Who this might be right for
CirrhosisAerobic ExercisesLifestyle Modification+9 more
King Chulalongkorn Memorial Hospital 50
Early research (Phase 1)Looking for participantsNCT04874428
What this trial is testing

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Insel Gruppe AG, University Hospital Bern 24
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Study completedNCT00043303
What this trial is testing

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

Who this might be right for
Liver FibrosisCirrhosis
InterMune 502
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Not applicableUnknownNCT04281303
What this trial is testing

Endoscopic Bariatric Therapy in NASH Cirrhosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla 10
Large-scale testing (Phase 3)Looking for participantsNCT06051617
What this trial is testing

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 402
Not applicableStudy completedNCT03246048
What this trial is testing

Long Term Follow-up of Hepatitis C Cured Patients

Who this might be right for
Chronic Hepatitis CChronic Liver DiseaseCirrhosis
Hospital Universitari Vall d'Hebron Research Institute 300
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Testing effectiveness (Phase 2)Study completedNCT06675929
What this trial is testing

Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Who this might be right for
Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
Boehringer Ingelheim 28
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Testing effectiveness (Phase 2)Ended earlyNCT05282121
What this trial is testing

Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Liver DiseasesHypertension, Portal
Boehringer Ingelheim 90
Not applicableStudy completedNCT05485714
What this trial is testing

Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis

Who this might be right for
Esophageal VaricesNon-alcoholic Fatty LiverCompensated Cirrhosis
United Arab Emirates University 73
Next Page